Table 3.
Mean ± SD values of bone density parameters in the studied groups with hepatitis C virus infection
| A (n = 31) | B (n = 29) | Total (n = 60) | Z- score | P value | |
| Head | 1.226 ± 0.394 | 1.12 ± 0.383 | 1.173 ± 0.389 | -0.16 ± 0.42 | 0.297 |
| Arm | 1.063 ± 1.223 | 0.89 ± 0.277 | 0.976 ± 0.883 | -0.916 ± 1.2 | 0.453 |
| Leg | 0.912 ± 0.225 | 0.969 ± 0.38 | 0.94 ± 0.311 | -1.13 ± 1.34 | 0.482 |
| Rib | 0.688 ± 0.248 | 0.869 ± 0.411 | 0.778 ± 0.349 | -1.31 ± 0.78 | 0.0431 |
| Pelvis | 0.839 ± 0.187 | 0.92 ± 0.238 | 0.879 ± 0.216 | -2.8 ± 1.53 | 0.051 |
| L Spine | 0.77 ± 0.207 | 0.901 ± 0.294 | 0.835 ± 0.261 | -2.43 ± 1.7 | 0.0511 |
| Total | 0.834 ± 0.281 | 0.913 ± 0.381 | 0.874 ± 0.334 | -1.98 ± 0.75 | 0.0361 |
1
Significance between total BMD of HCV patients vs control. BMD: Bone mineral density (g/cm2). HCV: Hepatitis C virus.